Atsushi Sanbe

Summary

Affiliation: Iwate Medical University
Country: Japan

Publications

  1. ncbi Dilated cardiomyopathy: a disease of the myocardium
    Atsushi Sanbe
    Department of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Iwate 028 3694, Japan
    Biol Pharm Bull 36:18-22. 2013
  2. ncbi Cardioprotective effect of nicorandil, a mitochondrial ATP-sensitive potassium channel opener, prolongs survival in HSPB5 R120G transgenic mice
    Atsushi Sanbe
    Department of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Iwate, Japan
    PLoS ONE 6:e18922. 2011
  3. ncbi Molecular mechanisms of α-crystallinopathy and its therapeutic strategy
    Atsushi Sanbe
    Department of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Iwate, Japan
    Biol Pharm Bull 34:1653-8. 2011

Detail Information

Publications3

  1. ncbi Dilated cardiomyopathy: a disease of the myocardium
    Atsushi Sanbe
    Department of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Iwate 028 3694, Japan
    Biol Pharm Bull 36:18-22. 2013
    ..Thus, effective prognostic determination and appropriate cardiac care depend on accurate molecular and genetic diagnoses...
  2. ncbi Cardioprotective effect of nicorandil, a mitochondrial ATP-sensitive potassium channel opener, prolongs survival in HSPB5 R120G transgenic mice
    Atsushi Sanbe
    Department of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Iwate, Japan
    PLoS ONE 6:e18922. 2011
    ..It is also known that progressive mitochondrial abnormalities and apoptotic cell death occur in the hearts of R120G TG mice. The role of mitochondrial dysfunction and apoptosis in disease progression, however, remains uncertain...
  3. ncbi Molecular mechanisms of α-crystallinopathy and its therapeutic strategy
    Atsushi Sanbe
    Department of Pharmacotherapeutics, School of Pharmacy, Iwate Medical University, Iwate, Japan
    Biol Pharm Bull 34:1653-8. 2011
    ..Moreover, recent findings have indicated that enhancement of HSP induction and inhibition of apoptotic cell death by mitochondrial protection may be a new therapeutic strategy for patients with crystallinopathy...